blog

AI’s Omnipresence and the Necessity of the Human Touch

Generative artificial intelligence (AI) has recently grabbed the public’s imagination.

Dillon Allie | August 18, 2023

AI | HDMZ

Chicago, Chicago, That Biotech Town

Last month, a Chicago-based biotech company called CellTrans was on the receiving end of a remarkable regulatory milestone: The company received FDA approval for the first cellular therapy for Type-1 diabetes.

Dillon Allie | July 19, 2023

Biotech | Life Sciences

HDMZ Named Top 10 Employer in Fortune’s Best Workplaces in Chicago 2023: Recognition Shows Our Plan to Serve Clients Even Better is Working

At HDMZ, we have a big, hairy, audacious goal: We aim to be the most admired marketing communications agency in the world for life sciences and biotech.

Dillon Allie | June 26, 2023

HDMZ News | HDMZ | Announcements

5 Developments in Cancer Research that HDMZ is Watching

Molecular biomarkers, precision medicine and artificial intelligence (AI) are all contributing to rapid developments in oncology.

Miriam Hyman, Scientific Content Writer | June 20, 2023

AI | Life Sciences | Cancer | Treatment

Lifestyle and Diet Changes at the Heart Of Rise in Cancer in Younger People

A recent study published in Nature revealed that since the ‘90s, cancer has been on the rise in people under the age of 50.

Natania Wright, Media Relations Account Executive | December 13, 2022

Life Sciences | Rare Disease | Cancer | Screenings | Treatment | Microbiome

Site Performance Analysis: Avoid Bias with a Data-Driven Approach

3 data-driven approaches to help avoid bias and optimize user experience when building a website.

Christine Bennett, Vice President, Digital Marketing | November 17, 2022

Big Data | Website Development | Website Optimization

HDMZ Adds Denis Moore to Leadership Team

As HDMZ’s new senior vice president of finance, Denis will oversee the agency’s financial operations to help achieve its business growth objectives and vision

John Kang, Senior Vice President, Public Relations | November 14, 2022

Press Releases | HDMZ News | HDMZ | Announcements

Technology and communication channels may change, but great stories remain timeless

At HDMZ, we focus on telling great stories to help brands making a difference in the world get the attention they deserve. It’s reflective of our agency’s culture, and is woven into the fabric of our DNA.

Seth Schwartz, VP, Business Development | November 8, 2022

Story | Writing

With Major Government Support, Biotech and Life Sciences Likely Heading Into Innovation Renaissance

Read this week’s blog post to see how Biden’s new executive order may spark biotech, healthcare and life sciences innovations and startups.

Azeem Zeekrya, Associate Director, Scientific Communications | October 24, 2022

Biotech | Life Sciences | Current Affairs

Regulatory Review: Unsung FDA approvals for rare disease in the 3rd quarter

In Q3 2022, several rare disease therapies became the first approved for their indications. Read more about under-the-radar FDA approvals for rare disease.

Katy Steele, Scientific Content Writer | October 18, 2022

FDA | FDA approved | Rare Disease